Trial Profile
C-Reactive Protein Does not Elevate in Half of Pneumonia Cases for the Entire Observation Period of Pneumonia During Tocilizumab Treatment for Rheumatoid Arthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Sep 2015
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- 02 Sep 2015 New trial record